Gates Package — page 209

Reference # G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Agreement Type Effective Date Expii tion Da External Parties Defense Threat Reduction Agency (DTRA) (DoD), Leidos Biomedical Research, Inc. (was SAIC- *Lead Pl 2016-0230 Letter of Intent/MOU 3/18/2016} Frederick, Inc. (Science Applications Heinrich Feldmann 2016-0233 Research Collaboration Agreement 5/25/2016] 5/25/2019]University of North Carolina at Chapel Hill Kanta Subbarao 2016-0238 Gift 5/25/2016] 3/31/2018] Washington University in St. Louis Herbert Morse 2016-0269 Letter of Intent/MOU 3/23/2016] University of Michigan Michael Otto Uniformed Services University of the Health 2016-0271 Letter of Intent/MOU 3/22/2016} Sciences (USUHS; USU) (DoD) Harry Malech 2016-0313 CTA - Clinical Trial Agreement 5/27/2016 SAB BIOTHERAPEUTICS, INC. Richard Davey 2016-0323 CRADA 5/11/2017] 5/11/2018]|Gilead Sciences, Inc Malcolm Martin 2016-0354 CTA - Clinical Trial Agreement 6/27/2016 Gilead Sciences, Inc H Clifford Lane Foundation for the National Institutes of Health, 2016-0359 Gift 8/25/2016} 12/31/2020] Inc. (FNIH), Pew Charitable Trusts [US] Walter Reed Army Institute of Research (WRAIR) 2016-0367 Research Collaboration Agreement 1/16/2017] 1/16/2023|(DoD) Jeffrey Cohen 2016-0373 CTA - Clinical Trial Agreement 5/3/2016 Sanofi US Services Inc. Elizabeth Kang The University of Tennessee Health Science Center 2016-0379 Research Collaboration Agreement 5/20/2016] 5/20/2017}[US] Kathryn Zoon The University of Tennessee Health Science Center 2016-0379 Research Collaboration Agreement 5/20/2016] 5/20/2017][US] Kathryn Zoon Bill & Melinda Gates Foundation (BMGF), 2016-0401 Gift 3/8/2017} 4/30/2018] University of Georgia Yasmine Belkaid Biomedical Advanced Research and Development Authority (BARDA) (DHHS), GlaxoSmithKline LLC 2016-0407 CTA - Clinical Trial Agreement 11/7/2016] _11/7/2017}(GSK) Jeffrey Cohen Biomedical Advanced Research and Development Authority (BARDA) (DHHS), GlaxoSmithKline LLC 2016-0407 CTA - Clinical Trial Agreement 11/7/2016] 11/7/2017] (GSK) Kanta Subbarao Biomedical Advanced Research and Development Authority (BARDA) (DHHS), GlaxoSmithKline LLC 2016-0407 CTA - Clinical Trial Agreement 11/7/2016] _11/7/2017}(GSK) Jeffrey Cohen Biomedical Advanced Research and Development Authority (BARDA) (DHHS), GlaxoSmithKline LLC 2016-0407 CTA - Clinical Trial Agreement 11/7/2016] 11/7/2017|(GSK) Jeffrey Cohen